Skip to content

Public FDA record

Z-1474-2026: Campy CVA Medium 100/PK, R01272

Recall record Z-1474-2026 for Remel, Inc. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1474-2026
Company in FDA record
Remel, Inc
FDA classification date
Feb 26, 2026
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Customer complaints report low to no recovery of Campylobacter Jejuni ATCC 33291 on identified lot of medium.

Source facts

Action
On February 5, 2026, the firm notified affected customers via Urgent Medical Device Recall letter. Customers were instructed to review test results and destroy any remaining inventory of the affected lot.
Initiated
2026-02-05
Root cause
Under Investigation by firm
Distribution
US Nationwide distribution in the states of AZ, CO, IL, NJ, OH, TN, WA.
Recall number
Z-1474-2026
Recall status
Open, Classified
CDRH record ID
218618
FDA classified
2026-02-26
Recall event number
98403

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗